CPGR
  • Home
  • About Us
  • Services
    • Genomics
    • Proteomics
    • Routine Testing
    • Training
    • Bespoke Projects
    • Omics Start-up Accelerator
    • Terms of Service
  • FAQ
  • Register Project
  • Contact Us
Select Page

Can Genomics invigorate medical innovation on the African continent?

by Dr. Reinhard Hiller | Sep 22, 2014 | Blog, Emerging markets, Innovation management, The "Omics" Revolution

Yes! If a set of other components is in place to make a complex innovation equation work… Introduction Genomics holds great promises for drug development through the identification of new drug targets, better understanding of disease mechanism, and the elucidation of...

Can Genomics contribute to South Africa’s GDP? – A thought experiment with crude numbers…

by Dr. Reinhard Hiller | Sep 19, 2014 | Blog, Emerging markets, The "Omics" Revolution

My short answer to this is, yes, but the real value of Genomics goes beyond an economic return and cannot be captured easily in dollars and cents! Background According to US-based non-profit research organisation Battelle, the Human Genome Project (HGP) contributed...

Highly concentrated scientific productivity and its impact on Africa

by Dr. Reinhard Hiller | Jul 15, 2014 | Blog, Emerging markets, Innovation management, R&D productivity

A recent paper in PLoS one [1] suggests that less than 1% of the globally active scientific community accounts for about 42% of all research output (measure = scientific publications; observation period = 1996-2011). If only high-impact papers are considered, a core...

A snapshot of global trends, challenges and drivers of success in Research & Development (R&D)

by Dr. Reinhard Hiller | May 6, 2014 | Blog, Emerging markets, R&D productivity

A recent publication by Battelle provides a global overview and forecast of R&D spending as well as related challenges and drivers of success. What follows is a summary of key messages (text and figures), extracted from the Battelle report (2014 Global R&D...

How industry dynamics force CROs to innovate and create opportunities for building biotech capacity in Africa

by Dr. Reinhard Hiller | Sep 11, 2013 | Blog, Emerging markets

Overview While optimists have labelled the early 2000s as the dawn of the ‘Biomedical Century’ (1), a little more than 10 years into it many are bearish when thinking about the sector’s prospects. Among other factors, this viewpoint is guided by the declining R&D...

Considerations regarding a viable technology platform model

by Dr. Reinhard Hiller | Aug 14, 2013 | Blog, Emerging markets, Innovation management

In many countries, developed and emerging, research infrastructure (RI) is considered either an entitlement by the academic elite or an expense by those holding the purse strings. In my mind, it is neither! Rather, it is an investment made in service of a particular...
« Older Entries

Recent Posts

  • Sars-CoV-2, unintended affects
  • Microbiome
  • Managing laboratory information in the cloud to support a rapid and scalable response to the Covid-19 pandemic in South Africa
  • CPGR, Artisan Biomed, together with partners, initiate CHIC (Cape Health Innovation Campus)
  • Artisan Biomed Partners with Cortex Group to Develop Pan-African Precision Medicine Solutions.

Recent Comments

    Archives

    • Jul 2020
    • Jun 2020
    • Apr 2020
    • Nov 2019
    • Jul 2019
    • Jun 2019
    • May 2019
    • Apr 2019
    • Feb 2019
    • Oct 2018
    • Sep 2018
    • Aug 2018
    • Apr 2018
    • Jan 2018
    • Nov 2017
    • Oct 2017
    • Sep 2017
    • Apr 2017
    • Oct 2016
    • Sep 2016
    • Apr 2016
    • Mar 2016
    • Feb 2016
    • Mar 2015
    • Sep 2014
    • Jul 2014
    • May 2014
    • Apr 2014
    • Dec 2013
    • Sep 2013
    • Aug 2013
    • Jul 2013
    • Jun 2013
    • Mar 2013
    • Nov 2012
    • Oct 2012
    • Jun 2012
    • Apr 2012
    • Mar 2012
    • Jan 2012
    • Dec 2011

    Categories

    • Announcement
    • Blog
    • Digital education
    • Emerging markets
    • Innovation management
    • Managerial practice
    • Online learning
    • Product launch
    • R&D productivity
    • The "Omics" Revolution
    • Uncategorized
    • VC financing

    Built by DevLabs | Maintained by DevLabs

    Click here for COVID-19 South Africa Coronavirus news and information portal